FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+38%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$30.4B
AUM Growth
+$7.6B
(+33%)
Cap. Flow
+$220M
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
34%
Holding
622
New
73
Increased
196
Reduced
171
Closed
128
Top Buys
| 1 |
T-Mobile US
TMUS
|
$436M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$150M |
| 3 |
Shake Shack
SHAK
|
$147M |
| 4 |
Datadog
DDOG
|
$140M |
| 5 |
Lowe's Companies
LOW
|
$109M |
Top Sells
| 1 |
Microsoft
MSFT
|
$206M |
| 2 |
NVIDIA
NVDA
|
$160M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$153M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$136M |
| 5 |
CrowdStrike
CRWD
|
$118M |
Sector Composition
| 1 | Technology | 33.43% |
| 2 | Healthcare | 21.84% |
| 3 | Consumer Discretionary | 15% |
| 4 | Communication Services | 9.98% |
| 5 | Financials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARCE
351
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $1.05M | ﹤0.01% |
24,146
-143,948
| -86% | -$6.26M |
|
352
Keysight
KEYS
$28.9B
| $1.05M | ﹤0.01% |
+10,395
| New | +$1.05M |
|
353
Biogen
BIIB
$20.6B
| $1.04M | ﹤0.01% |
3,867
-159,223
| -98% | -$42.6M |
|
354
Vipshop
VIPS
$8.45B
| $1.04M | ﹤0.01% |
52,000
-35,000
| -40% | -$697K |
|
355
Welltower
WELL
$112B
| $1.03M | ﹤0.01% |
19,904
| – | – |
|
356
Black Diamond Therapeutics
BDTX
$167M
| $1.01M | ﹤0.01% |
24,000
+7,000
| +41% | +$295K |
|
357
Carlyle Group
CG
$23.1B
| $988K | ﹤0.01% |
35,417
-58,037
| -62% | -$1.62M |
|
358
Garmin
GRMN
$45.7B
| $955K | ﹤0.01% |
9,796
-23,665
| -71% | -$2.31M |
|
359
General Dynamics
GD
$86.8B
| $940K | ﹤0.01% |
6,290
| – | – |
|
360
Blackstone Mortgage Trust
BXMT
$3.45B
| $935K | ﹤0.01% |
38,813
+10
| +0% | +$241 |
|
|
INFO
361
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $925K | ﹤0.01% |
12,254
-63,066
| -84% | -$4.76M |
|
362
Cheniere Energy
CQP
$26.1B
| $924K | ﹤0.01% |
26,416
| – | – |
|
|
DADA
363
DELISTED
Dada Nexus
DADA
| $892K | ﹤0.01% |
+39,978
| New | +$892K |
|
|
KRTX
364
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $892K | ﹤0.01% |
+8,000
| New | +$892K |
|
365
Zymeworks
ZYME
$1.14B
| $866K | ﹤0.01% |
24,000
+4,000
| +20% | +$144K |
|
366
Aurinia Pharmaceuticals
AUPH
$1.63B
| $813K | ﹤0.01% |
50,000
-6,000
| -11% | -$97.6K |
|
367
Wells Fargo
WFC
$253B
| $806K | ﹤0.01% |
31,474
| – | – |
|
368
Royalty Pharma
RPRX
$15.6B
| $801K | ﹤0.01% |
+16,500
| New | +$801K |
|
|
DCPH
369
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $776K | ﹤0.01% |
13,000
+9,000
| +225% | +$537K |
|
370
TotalEnergies
TTE
$133B
| $765K | ﹤0.01% |
19,890
-8,134
| -29% | -$313K |
|
371
Philip Morris
PM
$251B
| $745K | ﹤0.01% |
10,631
| – | – |
|
372
Ascendis Pharma
ASND
$12.5B
| $740K | ﹤0.01% |
5,000
| – | – |
|
373
FibroGen
FGEN
$48.9M
| $730K | ﹤0.01% |
720
| – | – |
|
374
Best Buy
BBY
$16.1B
| $725K | ﹤0.01% |
+8,312
| New | +$725K |
|
|
TBIO
375
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $717K | ﹤0.01% |
+40,000
| New | +$717K |
|